Reacts with: Human, Has cross-reactivity in IHC with human Claudin 18.1 and Claudin 18.2
Specificity
Recognize human Claudin 18.1 and Claudin 18.2
Immunogen
A synthetic peptide corresponding to the human Claudin 18
Preparation
Produced in rabbits immunized with a synthetic peptide corresponding to the human Claudin 18, and purified by antigen affinity chromatography.
Source
Monoclonal Rabbit IgG Clone #179
Purification
Protein A
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
Immunochemical staining of human Claudin 18 in human stomach with rabbit monoclonal antibody at 1:10000 dilution, formalin-fixed paraffin embedded sections.
Immunochemical staining of human Claudin 18 in human stomach with rabbit monoclonal antibody at 1:10000 dilution, formalin-fixed paraffin embedded sections.
Immunochemical staining of human Claudin 18 in human stomach with rabbit monoclonal antibody at 1:10000 dilution, formalin-fixed paraffin embedded sections.
Claudins family member Claudin18 (CLDN18) is a four-pass transmembrane protein with two extracellular loops and cytoplasmic N- and C-tails found in tight junctions. CLDN18 modulates paracellular permeability, polarity, and signaling. CLDN18 deficiency has been associated with atrophic gastritis, spasmolytic polypeptide-expressing metaplasia (SPEM), and asthma. Lung-specific CLDN18.1 modulates alveolar epithelial type II (AT2) cell proliferation and organ size. Restoration of CLDN18.1 expression in human lung cancer cells has been shown to suppress proliferation, inhibiting the IGF-1R/AKT axes. Not expressed in other healthy tissues, gastric mucosa-specific isoform CLDN18.2 expression manifests in primary gastric cancers. CLDN18.2 at the surface of epithelial tumor cells is a target in antibody and CAR-therapies currently in development.
title: A transmembrane scaffold from CD20 helps recombinant expression of a chimeric claudin 18.2 in an in vitro coupled transcription and translation system. authors: Yao Wang; Shaoting Weng; ...; Lin Wang journal: Protein expression and purification date: 2024-01-01 pmid: 37952787 doi: 10.1016/j.pep.2023.106392 cited_by_count: 1 techniques: Concentration Assay; Injection; Negative Control bioz_score: 92